Hypoglycemia
Insulin aspart biosimilar safe for pump therapy use in type 1 diabetes
A follow-on therapy to insulin aspart was shown to be safe and effective for pump use among adults with type 1 diabetes, with no increased incidence of unexplained hypoglycemia when compared with the reference product, according to findings from an open-label crossover study published in Diabetes Technology & Therapeutics.
Chronic pancreatitis in diabetes raises risk for hyperglycemia crisis, hypoglycemia
Chronic pancreatitis in the setting of diabetes further increases risks for serious complications, such as diabetic ketoacidosis, hyperglycemic hyperosmolar state and hypoglycemia, according to findings from a Taiwanese database analysis published in The Journal of Clinical Endocrinology & Metabolism.
High childhood HbA1c increases premature death risk in type 1 diabetes
Young adults with type 1 diabetes were nearly three times more likely to die before age 30 years if they had poor metabolic control during childhood, according to findings from a Swedish registry-based study.
Insulin pump therapy viable option vs. injections for older adults
Older adults with type 1 diabetes may be able to reduce HbA1c and the occurrence of hypoglycemia, diabetic ketoacidosis and hospitalization by using subcutaneous insulin infusion instead of insulin injection therapy, according to findings published in Diabetic Medicine.
Mobile closed-loop insulin system bests sensor-augmented pump in preventing hypoglycemia
Patients with type 1 diabetes may be able to avoid hypoglycemia more effectively without an increase in hyperglycemic episodes if they use a mobile closed-loop control system instead of a sensor-augmented pump, according to findings published in Diabetes Care.
Dulaglutide better vs. insulin glargine, glimepiride for Chinese adults aiming to lower HbA1c without weight gain, hypoglycemia
More Chinese adults with type 2 diabetes reduced their HbA1c to below 7% while not gaining weight or experiencing hypoglycemia when assigned dulaglutide vs. glimepiride or insulin glargine, according to findings published in the Journal of Diabetes Investigation.
Most diabetes apps lack effective ‘action prompts’ during hyperglycemia, hypoglycemia
Detailed directives based on proven practice for hypoglycemia and hyperglycemia treatment are not always features of diabetes apps, which means people with type 2 diabetes must be careful when selecting apps to help manage their diabetes, according to findings published in Diabetes/Metabolism Research and Reviews.
Severe hypoglycemia, CV events share ‘bidirectional relationship’
Adults with type 2 diabetes are at increased risk for severe hypoglycemia after a cardiovascular event and also are at increased risks for cardiovascular events following severe hypoglycemia, indicating a bidirectional relationship between severe hypoglycemia and CV events for this population, according to findings published in Diabetes Care.
Severe hypoglycemia contributes to diminished cognitive ability for older adults with type 1 diabetes
Cognitive abilities such as executive function, language and episodic memory are all negatively affected by severe hypoglycemia in adults with type 1 diabetes aged at least 60 years, according to findings published in Diabetes Care.
CGM scanned only intermittently yields ‘stable’ quality of life, reduces hypoglycemia vs. fingerstick tests
When adults with type 1 diabetes use an intermittently scanned continuous glucose monitor, they do not have to sacrifice quality of life to experience benefits, such as fewer hypoglycemia episodes and hospital visits, according to findings published in Diabetes Care.